Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > COMMENTARY
COMMENTARY
-
Frustrating Outcome for Industry: Exceptional NHI Price Reduction for Long-listed Drugs
February 13, 2006
-
Requirements for External IRBs to Be Relaxed
February 13, 2006
-
Astellas' Inventorship Issue with Professor Ochiai - What If This Were a US Case?
February 6, 2006
-
COMMENTARY 2 articles
January 30, 2006
-
JPLA SEMINAR
January 30, 2006
-
Maurer's Healthcare Insight (72)
January 30, 2006
-
Astellas' Inventorship Issue with Professor Ochiai - What If This Were a US Case?
January 30, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (II) -2-
January 30, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (II) -1-
January 30, 2006
-
From "Replacement" to "Addition": Prescription Form
January 23, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (I) -2-
January 23, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (I) -1-
January 23, 2006
-
A Happy Year 2006 to Japanese Pharmaceutical Stocks!
January 23, 2006
-
Industry Should Insist on Brand Average Market Price Principle
January 16, 2006
-
The Bottom of the Tornado
January 16, 2006
-
<New Year's commentary>Looking at the Pharma Industry Backward from 2009 -1- Sugio Seko, President Pharma Marketing Survey Research Laboratory (December, 2005)
January 9, 2006
-
<New Year's commentary>Looking at the Pharma Industry Backward from 2009 -2- Sugio Seko, President Pharma Marketing Survey Research Laboratory (December, 2005)
January 9, 2006
-
Schrodinger's Cat
December 12, 2005
-
Top Wholesalers Cut Costs to Offset Declines in Gross Profits
December 5, 2005
-
Importance of Framing
November 21, 2005
